Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.

Article  CAS  PubMed  Google Scholar 

Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;6:2094–101.

Article  Google Scholar 

Wood IS, Wang B, Jenkins JR, Trayhurn P. The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. Biochem Biophys Res Commun. 2005;337:422–9.

Article  CAS  PubMed  Google Scholar 

Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:701–21.

Article  CAS  PubMed  Google Scholar 

Point W, Dinarello CA. IL-18: A T H 1 -inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 1999;103:11–24.

Article  Google Scholar 

Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol. 1996;173:230–5.

Article  CAS  PubMed  Google Scholar 

Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001;12:53–72.

Article  CAS  PubMed  Google Scholar 

Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFN ␥ -inducing Factor) Induces IL-8 and IL-1 ␤ via TNF ␣ Production. J Clin Invest. 1998;101:711–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Netea MG, Kullberg BJ, Verschueren I, Van Der Meer JW. Interleukin‐18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin‐1β. Eur J Immunol. 2000;30:3057–60.

Article  CAS  PubMed  Google Scholar 

Kashiwamura S, Ueda H, Okamura H. Roles of interleukin-18 in tissue destruction and compensatory reactions. J Immunother. 2002;25:4–11.

Article  Google Scholar 

Netea MG, Joosten LA, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ, et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med. 2006;12:650–6.

Article  CAS  PubMed  Google Scholar 

Lindegaard B, Matthews VB, Brandt C, Hojman P, Syberg S, Rudnicka C, et al. Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice. Diabetes. 2013;62:1–42.

Article  Google Scholar 

Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol. 2000;12:59–63.

Article  CAS  PubMed  Google Scholar 

Esposito K. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72.

Article  CAS  PubMed  Google Scholar 

Olusi SO, Al-Awadhi A, Abraham M. Relations of serum interleukin 18 levels to serum lipid and glucose concentrations in an apparently healthy adult population. Horm Res. 2003;60:29–33.

CAS  PubMed  Google Scholar 

Zilverschoon GRC, Tack CJ, Joosten LAB, Kullberg BJ, Van Der Meer JWM, Netea MG. Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes. 2008;32:1407–14. https://doi.org/10.1038/ijo.2008.109.

Article  CAS  Google Scholar 

Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 1964;239:375–80.

Article  CAS  PubMed  Google Scholar 

de Assis-Ferreira, Saldanha-Gama R, de Brito NM, Renovato-Martins M, Simões RL, Barja-Fidalgo C, Vargas da Silva S. Obesity enhances the recruitment of mesenchymal stem cells to visceral adipose tissue. J Mol Endocrinol. 2021;67:15–26. https://doi.org/10.1530/JME-20-0229.

Article  PubMed  Google Scholar 

da Silva SV, Renovato-Martins M, Ribeiro-Pereira C, Citelli M, Barja-Fidalgo C. Obesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis. Obesity. 2016;24. https://doi.org/10.1002/oby.21660.

Emont MP, Jacobs C, Essene AL, Pant D, Tenen D, Colleluori G, et al. A single-cell atlas of human and mouse white adipose tissue. Nature. 2022;603:926–933.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Castor MGM, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, et al. The CCL3/Macrophage Inflammatory Protein-1α–Binding Protein Evasin-1 Protects from Graft-versus-Host Disease but Does Not Modify Graft-versus-Leukemia in Mice. The Journal of Immunology 2010;184. https://doi.org/10.4049/jimmunol.0902614.

Divoux A, Tordjman J, Lacasa D, Veyrie N, Hugol D, Aissat A, et al. Fibrosis in human adipose tissue: Composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59. https://doi.org/10.2337/db10-0585.

Aron-Wisnewsky J, Julia Z, Poitou C, Bouillot JL, Basdevant A, Chapman MJ et al. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab. 2011;96. https://doi.org/10.1210/jc.2010-2378.

Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T, et al. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA. 2007;104. https://doi.org/10.1073/pnas.0611523104.

Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334. https://doi.org/10.1056/nejm199602013340503.

Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med. 1995;1. https://doi.org/10.1038/nm1295-1311.

Zhang Y, Guo KY, Diaz PA, Heo M, Leibel RL. Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol. 2002;282. https://doi.org/10.1152/ajpregu.00392.2001.

Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75. https://doi.org/10.1152/physrev.1995.75.3.473.

Wang RH, Kim HS, Xiao C, Xu X, Gavrilova O, Deng CX. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Investig. 2011;121. https://doi.org/10.1172/JCI46243.

Gross DN, Van Den Heuvel APJ, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene. 2008;27. https://doi.org/10.1038/onc.2008.25.

Wang H, Capell W, Yoon JH, Faubel S, Eckel RH. Obesity development in caspase-1-deficient mice. Int J Obes 2014;38. https://doi.org/10.1038/ijo.2013.59.

Kimura H, Karasawa T, Usui F, Kawashima A, Endo Y, Kobayashi M, et al. Caspase-1 deficiency promotes high-fat diet-induced adipose tissue inflammation and the development of obesity. Am J Physiol Endocrinol Metab. 2016;311. https://doi.org/10.1152/ajpendo.00174.2016.

Stienstra R, Joosten LAB, Koenen T, Van Tits B, Van Diepen JA, Van Den Berg SAA, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010;12. https://doi.org/10.1016/j.cmet.2010.11.011.

Kotas ME, Jurczak MJ, Annicelli C, Gillum MP, Cline GW, Shulman GI, et al. Role of caspase-1 in regulation of triglyceride metabolism. Proc Natl Acad Sci USA. 2013;110. https://doi.org/10.1073/pnas.1301996110.

Zhang X, Luo S, Wang M, Cao Q, Zhang Z, Huang Q, et al. Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation. Nat Commun. 2022;13. https://doi.org/10.1038/s41467-022-35256-8.

Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4. https://doi.org/10.3389/fimmu.2013.00289.

Murphy AJ, Kraakman MJ, Kammoun HL, Dragoljevic D, Lee MKS, Lawlor KE, et al. IL-18 production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell Metab. 2016;23. https://doi.org/10.1016/j.cmet.2015.09.024.

Ahmad R, Thomas R, Kochumon S, Sindhu S. Increased adipose tissue expression of IL-18R and its Ligand IL-18 associates with inflammation and insulin resistance in obesity. Immun Inflamm Dis. 2017;5. https://doi.org/10.1002/iid3.170.

Hung J, McQuillan BM, Chapman CML, Thompson PL, Beilby JP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol. 2005;25. https://doi.org/10.1161/01.ATV.0000163843.70369.12.

Zhuang H, Han J, Cheng L, Liu SL. A positive causal influence of IL-18 levels on the risk of T2DM: a Mendelian randomization study. Front Genet. 2019;10. https://doi.org/10.3389/fgene.2019.00295.

Gateva A, Kamenov Z, Karamfilova V, Assyov Y, Velikova T, El-Darawish Y, et al. Higher levels of IL-18 in patients with prediabetes compared to obese normoglycaemic controls. Arch Physiol Biochem. 2020;126. https://doi.org/10.1080/13813455.2018.1555667.

Oliveira MS, Rheinheimer J, Moehlecke M, Rodrigues M, Assmann TS, Leitão CB, et al. UCP2, IL18, and miR-133a-3p are dysregulated in subcutaneous adipose tissue of patients with obesity. Mol Cell Endocrinol. 2020;509. https://doi.org/10.1016/j.mce.2020.110805.

Trøseid M, Seljeflot I, Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol. 2010;9. https://doi.org/10.1186/1475-2840-9-11.

Giorgino F, Leonardini A, Laviola L, Perrini S, Natalicchio A. Cross-talk between PPARγ and insulin signaling and modulation of insulin sensitivity. PPAR Res. 2009. https://doi.org/10.1155/2009/818945.

Young MT, Phelan MJ, Nguyen NT. A Decade Analysis of Trends and Outcomes of Male vs Female Patients Who Underwent Bariatric Surgery. J Am Coll Surg. 2016;222:226–231.

Article  PubMed  Google Scholar